Category

News Media

Debunking reefer madness with some of the science, evidence and real world experiences.

By | Drug Policy, Government, News Media


Cannabis and driving studies
June 22, 2017
American Journal of Public Health (ajph)
Crash Fatality Rates After Recreational Marijuana Legalization in Washington and Colorado. Evaluate motor vehicle crash fatality rates in the first 2 states and compare them with motor vehicle crash fatality rates in similar states without recreational marijuana legalization.
Automobile crash fatality rates in Washington and Colorado were no different from comparable states without legal recreational cannabis.
http://ajph.aphapublications.org/doi/abs/10.2105/AJPH.2017.303848

2015

The U.S. Department of Transportation report suggests that while cannabis could potentially impair driving skills, its findings in other research suggest drivers under the influence of cannabis are actually more cautious. “Subjects in most of the simulator and instrumented-vehicle studies on marijuana are driving typically drive slower, follow other cars at greater distances and take fewer risks than when sober,” the report said.
http://www.nhtsa.gov/staticfiles/nti/pdf/812117-Drug_and_Alcohol_Crash_Risk.pdf

2003 and 2007
Canada Safety Council
Drivers under the influence of cannabis are acutely aware of their impairment. They consciously try to drive more cautiously, by slowing down, focusing their attention and avoiding risks.

Cannabis and impaired driving studies
Sept. 2002 – June 2017
http://calgary420.ca/impaired/#driving
or PDF document http://calgary420.ca/pdf/driving/cannabis-impaired-driving-2017.pdf

Cannabis addiction
Business Insider – We took a scientific look at whether weed or alcohol is worse for you, deaths and addiction
: “More than 30,700 Americans died from alcohol-induced causes in 2014
There have been zero documented deaths from marijuana use alone.
Marijuana appears to be significantly less addictive than alcohol.”
http://www.businessinsider.com/alcohol-marijuana-which-worse-health-2017-11

Philippe Lucas, VP at Tilray, a research scholar with the University of Victoria’s Centre for Addictions Research of BC, said cannabis dependency isn’t as severe as some make it out to be. Normally, people are able to give up cannabis on their own, compared to severe drugs,
Lucas, the lead author in a September 2015 study in the “International Journal of Drug Policy”, a peer-reviewed publication found medical cannabis can be a safe and successful substitution for other addictions to alcohol 25% reduction, 32% for opiates, 12% tobacco, and more. The study has been updated and published August 2017, “Rationale for cannabis-based interventions in the opioid overdose crisis” in the Harm Reduction Journal.

Organized crime
Canadian Drug Policy Coalition – Organized crime in the cannabis market:- Evidence and Implications
“2. Unsubstantiated media and police reports portray the cannabis industry as dominated by organized crime.”
“3. Evidence suggests a very low involvement of organized crime in the cannabis industry in Canada; the majority of those in the industry tend to be non-violent and have minimal, if any, involvement with other criminal activities
http://drugpolicy.ca/wp-content/uploads/2016/11/CDPC_Submission_Cannabis-and-Organized-Crime_Aug9-2016_Full-Final.pdf

Mental Health
The University of Alberta, O’Brien Institute for Public Health, Dr. Elaine Hyshka; Assistant Professor, School of Public Health.
November 2017 Dr. Elaine Hyshka, “There are also people who claim that cannabis is going to basically damage your brain when you use it, especially if you’re young, and that it’s going to contribute to the intellectual downfall of a generation. And that’s also not true,” she said.

A Controlled Family Study of Cannabis Users with and without Psychosis Harvard study published in 2014:
Evidenced that teen cannabis consumption is not lead to the development of schizophrenia later in life. The study compared families with a history of schizophrenia to those without. The study also examined non-psychotic cannabis consumers and non-consuming participant controls.
The results of the current study suggest that having an increased familial morbid risk for schizophrenia may be the underlying basis for schizophrenia in cannabis users and not cannabis use by itself.

Also see real world experiences:
November 21, 2017
Washington governor John Horgan:
Don’t panic about legalized pot
The governor of is telling British Columbians to ignore most of the fear-mongering about the pending decriminalization of recreational pot in Canada.
http://www.news1130.com/2017/11/21/jay-inslee-bc-premier-dont-panic-legalized-pot/

April 2, 2017
Colorado governor John Hickenlooper:
“We had a lot of fears that we would see a real spike in teenage use, we would see real issues around edibles, a large increase in overall consumption,” the governor told Vassy Kapelos on this weekend’s edition of The West Block.
“And we haven’t seen any of that … We certainly look at (legalization) differently now than we did back then.”
https://globalnews.ca/news/3348196/as-legal-pot-looms-hopefully-you-guys-will-learn-from-our-mistakes-colorado-governor/

Dr. Susan C. Boyd, a B.C. researcher’s books “Killer Weed: Marijuana Grow Ops, Media and Justice”. about how law enforcement and media are not telling the facts and “Reefer madness is governmental” Note: Dr. Susan C. Boyd is a member of Liberal government “Task Force on Marijuana Legalization and Regulation”

Safe Cannabis Gardens
http://calgary420.ca/safe-garden

Health committee considers BILL C-45 (legalize cannabis)

By | Drug Policy, News Media

Created: September 11, 2017
Last update: September 18, 2017

Canadian Cannabis Flag

House of Commons Health Committee
considers BILL C-45
(cannabis, marijuana)


September 11, 2017 to September 15, 2017 recorded testimony on the government’s BILL C-45 (cannabis, marijuana).

Watch the hearings live on CPAC.ca

In Committee from the House of Commons Marijuana

Health committee – September 11, 2017 – Part 1
The committee reconvenes a week ahead of Parliament’s return to begin its hearings on C-45, the government’s bill to legalize marijuana. The proposed Cannabis Act would create a legal framework to control the production, distribution, sale and possession of recreational marijuana in Canada. Sales will be restricted to people age
www.cpac.ca/en/programs/in-committee-house-of-commons/episodes/52691406

Health committee – September 11, 2017 – Part 2
Former justice minister Anne McLellan, who chaired the federal task force on marijuana legalization, testifies as the committee continues its hearings on Bill C-45
www.cpac.ca/en/programs/in-committee-house-of-commons/episodes/52691427

Health committee – September 11, 2017 – Part 3
MPs continue their hearings on the government’s cannabis legislation (C-45), with a panel on provincial responsibilities and perspectives from the cannabis industry. The committee hears from Philippe Lucas (executive director, Canadian Medical Cannabis Council), Keith Jones (chair, government relations) and Robert Rae (director), both with the Canadian Hemp Trade Alliance
www.cpac.ca/en/programs/in-committee-house-of-commons/episodes/52691429

Health committee – September 11, 2017 – Part 4
Canadian Medical Association president Laurent Marcoux and his colleague Jeff Blackmer (vice-president of medical professionalism) are among the witnesses to testify as the committee continues its review of C-45, the federal government’s marijuana legalization bill. MPs also hear from Trevor Bhupsingh (director general, Law Enforcement and Border Strategies Directorate
www.cpac.ca/en/programs/in-committee-house-of-commons/episodes/52691431

Health committee – September 12, 2017 – Part 1
The following witnesses testify on Bill C-45: Thomas Carrique (deputy chief) and Mike Serr (deputy chief constable, drug advisory committee), who are all representing the Canadian Association of Chiefs of Police; Rick Barnum (deputy commissioner, investigation and organized crime) from the Ontario Provincial Police; and Mark Chatterbok (deputy chief of operations) with the Saskatoon Police Service
www.cpac.ca/en/programs/in-committee-house-of-commons/episodes/52691441

Health committee – September 12, 2017 – Part 2
The committee discusses justice and public safety issues as it continues its hearings on the government’s marijuana legislation (C-45). MPs hear from Neil Boyd (criminology professor, Simon Fraser University); Christian Leuprecht (political science professor, Royal Military College of Canada); Barreau du Québec representatives Paul-Matthieu Grondin (president), Luc Hervé Thibaudeau
www.cpac.ca/en/programs/in-committee-house-of-commons/episodes/52691461

Health committee – September 12, 2017 – Part 3
The committee hears about the experiences of other jurisdictions as it continues its review of the government’s marijuana legislation (C-45). The witnesses are Sam Kamin (professor of marijuana law and policy, University of Denver); Michael Hartman (executive director, Colorado Department of Revenue); Marc-Boris St-Maurice (NORML Canada) and Abigail Sampson (NORML Canada)
www.cpac.ca/en/programs/in-committee-house-of-commons/episodes/52691490

Health committee – September 12, 2017 – Part 4
MPs continue their review of Bill C-45, the federal government’s proposal to legalize marijuana. Committee members hear from Marco Vasquez (retired Colorado police chief), Andrew Freedman (Colorado’s former director of marijuana coordination) Kevin Sabet (president, Smart Approaches to Marijuana), and Kristi Weeks (government relations director, Washington State Department of Health)
www.cpac.ca/en/programs/in-committee-house-of-commons/episodes/52691571

Health committee – September 13, 2017 – Part 1
The committee holds its third day of hearings on C-45, the federal government’s Cannabis Act.
Jonathan Page (chief executive officer, Anandia Labs), John Conroy (criminal defence lawyer) (president NORML Canada) and John Dickie (president, Canadian Federation of Apartment Associations) take part in a panel on the household cultivation of cannabis plants. Under the proposed bill, adults would legally be able to grow up to four plants per household.
www.cpac.ca/en/programs/in-committee-house-of-commons/episodes/52691788

Health committee – September 13, 2017 – Part 2
MPs hear from Scott Bernstein (senior policy analyst, Canadian Drug Policy Coalition); Ian Culbert (executive director, Canadian Public Health Association); Dr. Christina Grant (member of the Canadian Paediatric Society’s adolescent health committee); Judith Renaud and Paul Renaud (respectively executive director and communications director, Educators for Sensible Drug Policy); and Peter A. Howlett (president)and Peter Vamos (executive director), both representing the organization Portage, which operates drug rehabilitation programs.
www.cpac.ca/en/programs/in-committee-house-of-commons/episodes/52691799

Health committee – September 13, 2017 – Part 3
MPs hear from the following witnesses on Bill C-45: Amy Porath (director of research and policy, Canadian Centre on Substance Use and Addiction); Drug Free Kids Canada representatives Marc Paris (executive director) and William J. Barakett (member of advisory council); and Maude Chapados and François Gagnon (scientific advisors, Institut national de santé publique du Québec).
www.cpac.ca/en/programs/in-committee-house-of-commons/episodes/52691801

Health committee – September 13, 2017 – Part 4
The following witnesses offer their viewpoints: Dr. Gabor Maté (addiction expert); Centre for Addiction and Mental Health representatives Benedikt Fischer (senior scientist, Institute for Mental Health Policy Research) and Bernard Le Foll (medical head, Addiction Medicine Service, Acute Care Program); Dr. Eileen de Villa (Toronto’s medical officer of health); Dr. Sharon Levy (director of the Adolescent Substance Abuse Program at Boston Children’s Hospital); as well as Michelle Suarly and Elena Hasheminejad (members of Ontario Public Health Association’s Cannabis Task Group).
www.cpac.ca/en/programs/in-committee-house-of-commons/episodes/52691803

Health committee – September 14, 2017 – Part 1
The following witnesses discuss prevention, treatment, and low-risk use: Michael DeVillaer (assistant professor, department of psychiatry and behavioural neurosciences, McMaster University); Mark Kleiman (professor of public policy, Marron Institute of Urban Management, New York University; Lynda G. Balneaves, (medical and non-medical cannabis researcher) and Karey Shuhendler (policy advisor, policy, advocacy and strategy), both from with the Canadian Nurses Association; Dr. Serge Melanson (New Brunswick Medical Society); and Dr. Robert Strang (Nova Scotia’s chief medical officer of health).
www.cpac.ca/en/programs/in-committee-house-of-commons/episodes/90009089

Health committee – September 14, 2017 – Part 2
Trina Fraser (lawyer and cannabis law expert) and Norm Keith (lawyer specializing in occupational health and safety) testify. Brenda Baxter, an official with the Department of Employment and Social Development’s workplace directorate, is the other witness.
www.cpac.ca/en/programs/in-committee-house-of-commons/episodes/90009091

Health committee – September 14, 2017 – Part 4 (3)
Witnesses discuss labelling and packaging as the committee holds another hearing on the government’s cannabis legislation (C-45). The panellists are David Hammond (professor, University of Waterloo’s School of Public Health and Health Systems), Mike Hammoud (president Atlantic Convenience Stores Association), and Non-Smokers’ Rights Association representatives Melodie Tilson (director of policy) and Pippa Beck (senior policy analyst).
www.cpac.ca/en/programs/in-committee-house-of-commons/episodes/90009092

Health committee – September 14, 2017 – Part 5 (4)
The witnesses for this panel are Steven Hoffman (professor, York University’s Faculty of Health), Beau Kilmer (co-director, RAND Drug Policy Research Centre), Kirk Tousaw, (criminal defence lawyer) (NORML Canada) and advocate for repealing cannabis prohibition), and Stephen Rolles (senior policy analyst, Transform Drug Policy Foundation).
www.cpac.ca/en/programs/in-committee-house-of-commons/episodes/52749534

Health committee – September 15, 2017 – Part 1
Ryan Vandrey (associate professor of psychiatry and behavioral sciences at Johns Hopkins University), Daniel Vigil (manager of marijuana health monitoring and research, Colorado Department of Public Health and Environment) and Dana Larsen (director, Sensible BC) are the witnesses for this panel.
www.cpac.ca/en/programs/in-committee-house-of-commons/episodes/90009095

Health committee – September 15, 2017 – Part 2
The witnesses for this session are BC Compassion Club Society representatives Hilary Black (founder) and Marcel Vandebeek (administrator), Jonathan Zaid (executive director) and Daphnée Elisma (Quebec representative), who are both with the group Canadians for Fair Access to Medical Marijuana, and the Department of Health’s Jacqueline Bogden (assistant deputy minister, Cannabis Legalization and Regulation Branch).
www.cpac.ca/en/programs/in-committee-house-of-commons/episodes/90009116

Health committee – September 15, 2017 – Part 3
Marijuana activists Marc and Jodie Emery take part in the committee’s hearings on Bill C-45, the federal government’s proposal to legalize recreational marijuana.
Lisa Holmes (mayor of Morinville, Alberta and president of the Alberta Urban Municipalities Association), Brock Carlton (CEO, Federation of Canadian Municipalities) and Bill Karsten (second vice-president, FCM) are the other witnesses for this panel on municipalities.
www.cpac.ca/en/programs/in-committee-house-of-commons/episodes/52691925


Live: ‘Naive’ to think criminal element will end with pot legalization, senior Mountie tells MPs

By | Drug Policy, News Media

September 11, 2017
CBC News
Health committee hears from senior government officials, RCMP on pot legislation

LIVE Commons health committee hearing on pot legislation

A senior RCMP officer says it would be “naive” to think organized crime in the cannabis market will be eliminated with the legalization of recreational marijuana.

www.cbc.ca/news/politics/health-committee-marijuana-legalization-1.4282569

2017 NORML Canada Conference

By | Drug Policy, Events Calender, News Media

2017 has proven to be a historic year in cannabis history. Through our annual conference, we bring together experts from all walks of the cannabis space, to help educate and engage Canadians in open, productive and thoughtful dialogue.

norml.ca/2017-norml-canada-conference

Saturday, September 9th, 2017

11:00 AM – NORML Canada – Opening Address
11:15 AM – Jamie Shaw (MMJ Canada), Irie Sellkirk (Emblem), Dessy Pavlova (CSSDP/Lift), Amy Brown (Canndo) – Women and Cannabis Panel
12:30 PM – Britney Guerra – Cannabis Entrepreneurship – Challenges and Triumphs
1:30 PM Lunch Break
2:00 PM – Alison Gordon – Navigating Businesses into the Legal Cannabis Market
3:00 PM – Marcus Richardson (Bubbleman), Kevin Furet (Cannabis Wheaton), Jose Domingez (Canveda), Matt Rogge (7Acres) – Cannabis Growing- Personal, Patients and Large Production
4:00 PM – Dana Larsen – Keynote
5:00 PM – Marcus Richardson – Bubbleman Brand
6:00 PM – Jodie Emery – The Princess of Pot
7:00 PM – NORML Canada – Closing Day 1 Remarks – John Conroy

Sunday September 10th

11:00 AM – NORML Canada – Welcome
11:15 AM – MP Nathaniel Erskine Smith – Keynote
12:30 PM – David Schaefer (BHOGart) Safe Extraction Methods
1:30 PM – Lunch
2:00 PM – Alan Park – Canadian Comedian Cures Cancer with Cannabis Oil
3:00 PM – Adam Greenblatt (Canopy Growth), Matt Mernagh (Peace Naturals), John Fowler (Supreme), Kevin Furet (Cannabis Wheaton), Shega Youngson (Canopy Growth) – From Grey to Green – Transitioning Into the Legal Cannabis Market.
4:00 PM – Paul Lewin – Dispensaries- The Legal Challenges and Legalization
5:00 PM – Executive Directors of NIMCA – the National Indigenous Medical Cannabis Association
6:00 PM – Jonathan Zaid (CFAMM) – Cannabis and Driving
6:30 PM – NORML Canada Conference Closing Remarks – John Conroy

Liberal’s legalize cannabis legislation introduced

By | Drug Policy, News Media


Lift sponsor

 

We can’t help but feel the cannabis act is more decriminalization then legalization. Also of much concern is the criminal penalties and restrictions are much more harsher for cannabis then alcohol, tobacco and even many violent crimes.

Note: The impaired driving likely won’t hold up to constitutional challenges in the courts. calgary420.ca/pdf/driving/driving-impaired.pdf

Growing restricted to 4 plants per home and 1 meter height max. Tobacco cultivation limit is 15kg per year for each adult person living at the residence.
Note: Easy enough to control height with plant training.

 

April 13, 2017

Government of Canada news release (legalize cannabis legislation) (PDF)
calgary420.ca/pdf/cannabis_news-release.pdf

Government of Canada Cannabis Act (PDF)
calgary420.ca/pdf/cannabis_act.pdf



April 13, 2017

Emily Mertz, Web Producer – Global News Calgary

What do you think the legal minimum age to buy marijuana in Alberta should be?

See age poll left side after “City of Calgary” and before “Calgary 420 Cannabis Community”

globalnews.ca/news/3377809/alberta-cities-province-respond-to-federal-legislation-on-legalizing-marijuana

September 4, 2002 marks the release of the Senate Special Committee on Illegal Drugs: “Cannabis: Our Position for a Canadian Public Policy.” with a recommended 16 year old age limit for consuming cannabis.


April 13, 2017
Shaun Frenette – CTV Calgary News

Re: Concerns about youth and driving under proposed marijuana laws.

Cannabis and impaired driving – PDF document calgary420.ca/pdf/driving/driving-impaired.pdf

Re: Calgary Mayor Naheed Nenshi brain science comment:

The long term real world schizophrenia data from the nineteen sixties (1960s) to twenty sixteen (2016) shows no sufficient increases even thought cannabis consumption has sufficiently increased over the same time period (over 50 years).


April 15, 2017
Mike Blanchard – 660 News Radio

A local marijuana advocate is urging the Alberta government to keep pot out of liquor stores once the stuff becomes legal

www.660news.com/2017/04/15/marijuana-advocate-cautions-selling-weed-alongside-booze/


A Framework for the Legalization and Regulation of Cannabis in Canada

By | Drug Policy, News Media

The Final Report of the Task Force on Cannabis Legalization and Regulation


TFMLR Dec. 13, 2016

Table of Contents

Foreword

Executive Summary

Chapter 1: Introduction
Our mandate
The Canadian context
A global perspective
Setting the frame
Public policy objectives
Engagement process
Guiding principles

Chapter 2: Minimizing Harms of Use
Introduction: a public health approach
Minimum age
Promotion, advertising and marketing restrictions
Cannabis-based edibles and other products
THC potency
Tax and price
Public education
Prevention and treatment
Workplace safety

Chapter 3: Establishing a Safe and Responsible Supply Chain
Introduction
Production
Distribution
Retail
Personal cultivation

Chapter 4: Enforcing Public Safety and Protection
Introduction
Illegal activities
Personal possession
Place of use
Impaired driving

Chapter 5: Medical Access
Introduction
One system or two?
Access
Affordability
Products
Public safety
Evidence and research

Chapter 6: Implementation
Capacity
Oversight
Co-ordination
Communication

Annex 1: Biographies of Task Force on Cannabis Legalization and Regulation Members
Annex 2: Terms of Reference
Annex 3: Acknowledgements
Annex 4: Discussion Paper ‘Toward the Legalization, Regulation and Restriction of Access to Marijuana’
Annex 5: Executive Summary: Analysis of consultation input submitted to the Task Force on Cannabis Legalization and Regulation

http://healthycanadians.gc.ca/task-force-marijuana-groupe-etude/framework-cadre/index-eng.php


Access to Cannabis for Medical Purposes Regulations (ACMPR)

By | Drug Policy, News Media

Access to Cannabis for Medical Purposes Regulations (ACMPR)

Legalize Yes

August 24, 2016

Part 2 — Production for Own Medical Purposes and Production by a Designated Person

Part 2 of the ACMPR sets out a registration framework that allows for personal-use and designated production of cannabis (including cultivation of plants and alteration of products) for medical purposes.

Note: The majority of Part 2 incorporates the requirements of the former MMAR and relevant section 56 CDSA exemptions that respond to the decision in R. v. Smith with required modifications to incorporate the production, storage and possession of products other than dried marihuana or plants. New provisions that did not form part of the previous framework include the following:

•Proof of possession and registration can be demonstrated through a registration certificate issued by Health Canada.

• Starting materials (i.e. seeds and plants) can be obtained through licensed producers.

• Interim supply of cannabis (until plants are ready) can be obtained through licensed producers.

• Security measures do not need to be listed on the registration application, but those registering to possess and produce cannabis must declare that security measures are in place to keep plants and products secure.

• Information sharing provisions have been expanded to enable proactive sharing of information on registered persons with P/T health care licensing authorities.

Indoor & outdoor grams, plants and storage amounts.

Grams Per Day = Plant Count

Producing cannabis safety and security
Information bulletin: safety and security considerations when producing cannabis for your own medical purposes

Applications for Production for Own Medical Purposes and Production by a Designated Person
http://healthycanadians.gc.ca/alt/pdf/drugs-products-medicaments-produits/buying-using-achat-utilisation/cannabis-medical/access-acces/personal-production-personnelle/registration-form-formulaire-inscription-eng.pdf

Guidance Document – Completing the Production for Own Medical Purposes and Production by a Designated Person Registration Form
http://healthycanadians.gc.ca/drugs-products-medicaments-produits/buying-using-achat-utilisation/cannabis-medical/access-acces/personal-production-personnelle/registration-instructions-inscription-eng.php

Licensed dealer testing of cannabis produced by individuals
http://healthycanadians.gc.ca/drugs-products-medicaments-produits/buying-using-achat-utilisation/cannabis-medical/access-acces/personal-production-personnelle/licensed-dealer-testing-analyse-distributeurs-autorises-eng.php

August 11, 2016 Understanding ACMPR
Understanding the New Access to Cannabis for Medical Purposes Regulations

Complete ACMPR Regulations
http://www.gazette.gc.ca/rp-pr/p2/2016/2016-08-24/html/sor-dors230-eng.php

Contact Health Canada Cannabis for medical purposes
Email: omc-bcm@hc-sc.gc.ca
Toll Free Phone: 1-866-337-7705

More Cannabis for medical purposes services and information
Health Canada Cannabis for medical purposes